Mexico - North America Chondroitin Sulfate Market Size & Outlook
Global Market
Related Markets
Mexico chondroitin sulfate market highlights
- The Mexico chondroitin sulfate market generated a revenue of USD 49.4 million in 2025 and is expected to reach USD 63.6 million by 2033.
- The Mexico market is expected to grow at a CAGR of 3.3% from 2026 to 2033.
- In terms of segment, bovine was the largest revenue generating source in 2025.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2025 | USD 49.4 million |
| Market revenue in 2033 | USD 63.6 million |
| Growth rate | 3.3% (CAGR from 2026 to 2033) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Poultry, Bovine, Shark, Swine, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, Mexico accounted for 3.9% of the global chondroitin sulfate market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 459.0 million by 2033.
Pharmaceutical industry in Mexico is one of the emerging industries in Latin America. It consists of a large number of domestic and multinational players engaged in manufacturing products including cancer treatment products, antibiotics, a variety of over-the-counter medicines, vaccines, and other products.
The Mexican law requires the companies distributing pharmaceuticals to have a manufacturing facility in the country, which is expected to contribute to foreign investments in the country. These initiatives are projected to drive the market growth. The country has a large number of aging populations suffering from chronic diseases such as diabetes, cancer, and cardiovascular.
No credit card required*
Publish Date: Jul 17, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| BRF SA ADR | View profile | 96,667 | Avenida das Nacoes Unidas, 8501 – 1st Floor, Pinheiros, Sao Paulo, SP, Brazil, 05425-070 | www.brf-global.com |
| Bioiberica | View profile | 251-500 | Barcelona, Catalonia, Spain, Europe | www.bioiberica.com/ |
| Seikagaku | View profile | 501-1000 | Marunouchi, Tokyo, Japan, Asia | www.seikagaku.co.jp/ |
| TSI Group | View profile | 101-250 | Eagle Farm, Queensland, Australia, Oceania | tsipharma.com.au |
| Bio-gen Extracts | View profile | 101-250 | Bangalore, Karnataka, India, Asia | www.bio-gen.in |
Mexico - North America Chondroitin Sulfate Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Chondroitin Sulfate Market Outlook will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 39.88% in 2025.
Horizon Databook has segmented the Mexico - North America chondroitin sulfate market based on poultry, bovine, shark, swine, synthetic covering the revenue growth of each sub-segment from 2021 to 2033.
Pharmaceutical industry in Mexico is one of the emerging industries in Latin America. It consists of a large number of domestic and multinational players engaged in manufacturing products including cancer treatment products, antibiotics, a variety of over-the-counter medicines, vaccines, and other products.
The Mexican law requires the companies distributing pharmaceuticals to have a manufacturing facility in the country, which is expected to contribute to foreign investments in the country. These initiatives are projected to drive the market growth. The country has a large number of aging populations suffering from chronic diseases such as diabetes, cancer, and cardiovascular.
- Mexico - North America Chondroitin Sulfate Market Source Outlook (Revenue, USD Million , 2021-2033)
- Bovine
- Swine
- Poultry
- Shark
- Synthetic
- Mexico - North America Chondroitin Sulfate Market Application Outlook (Revenue, USD Million , 2021-2033)
- Nutraceuticals
- Pharmaceuticals
- Animal Feed
- Personal Care & Cosmetics
- Others
Reasons to subscribe to Chondroitin Sulfate Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Chondroitin Sulfate Market Outlook databook
- Our clientele includes a mix of Chondroitin Sulfate Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - North America Chondroitin Sulfate Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - North America Chondroitin Sulfate Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Mexico - North America Chondroitin Sulfate Market, 2021-2033 (US$M)
Mexico chondroitin sulfate market statistics, by source, 2021-2033 (US$M)
